SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sintx Technologies, Inc. – ‘10-K’ for 12/31/17 – ‘EX-101.CAL’

On:  Thursday, 3/29/18, at 5:31pm ET   ·   For:  12/31/17   ·   Accession #:  1493152-18-4186   ·   File #:  1-33624

Previous ‘10-K’:  ‘10-K/A’ on 12/27/17 for 12/31/16   ·   Next:  ‘10-K’ on 3/11/19 for 12/31/18   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/29/18  Sintx Technologies, Inc.          10-K       12/31/17   81:6.8M                                   M2 Compliance/FA

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.13M 
 2: EX-23.1     Consent of Experts or Counsel                       HTML     26K 
 3: EX-23.2     Consent of Experts or Counsel                       HTML     26K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 6: EX-32       Certification -- §906 - SOA'02                      HTML     26K 
13: R1          Document and Entity Information                     HTML     54K 
14: R2          Consolidated Balance Sheets                         HTML    108K 
15: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
16: R4          Consolidated Statements of Operations               HTML     80K 
17: R5          Consolidated Statements of Stockholders' Equity     HTML     99K 
18: R6          Consolidated Statements of Cash Flow                HTML    139K 
19: R7          Consolidated Statements of Cash Flow                HTML     30K 
                (Parenthetical)                                                  
20: R8          Organization and Summary of Significant Accounting  HTML     88K 
                Policies                                                         
21: R9          Inventories                                         HTML     33K 
22: R10         Property and Equipment                              HTML     36K 
23: R11         Intangible Assets                                   HTML     32K 
24: R12         Fair Value Measurements                             HTML     62K 
25: R13         Accrued Liabilities                                 HTML     33K 
26: R14         Debt                                                HTML     56K 
27: R15         Equity                                              HTML     36K 
28: R16         Stock-Based Compensation                            HTML     73K 
29: R17         Income Taxes                                        HTML     47K 
30: R18         Commitment and Contingencies                        HTML     38K 
31: R19         401(k) Plan                                         HTML     28K 
32: R20         Restatement to Previously Issued 2016 Consolidated  HTML     46K 
                Balance sheet and Related Statements of                          
                Operations, Stockholders? Equity and Cash Flows                  
33: R21         Restatement to Previously Issued 2017 Condensed     HTML     89K 
                Consolidated Financial Statements                                
34: R22         Subsequent Events                                   HTML     34K 
35: R23         Organization and Summary of Significant Accounting  HTML    142K 
                Policies (Policies)                                              
36: R24         Organization and Summary of Significant Accounting  HTML     31K 
                Policies (Tables)                                                
37: R25         Inventories (Tables)                                HTML     32K 
38: R26         Property and Equipment (Tables)                     HTML     34K 
39: R27         Intangible Assets (Tables)                          HTML     33K 
40: R28         Fair Value Measurements (Tables)                    HTML     64K 
41: R29         Accrued Liabilities (Tables)                        HTML     32K 
42: R30         Debt (Tables)                                       HTML     42K 
43: R31         Stock-Based Compensation (Tables)                   HTML     79K 
44: R32         Income Taxes (Tables)                               HTML     43K 
45: R33         Commitment and Contingencies (Tables)               HTML     33K 
46: R34         Restatement to Previously Issued 2016 Consolidated  HTML     45K 
                Balance sheet and Related Statements of                          
                Operations, Stockholders? Equity and Cash Flows                  
                (Tables)                                                         
47: R35         Restatement to Previously Issued 2017 Condensed     HTML     41K 
                Consolidated Financial Statements (Tables)                       
48: R36         Organization and Summary of Significant Accounting  HTML     63K 
                Policies (Details Narrative)                                     
49: R37         Organization and Summary of Significant Accounting  HTML     33K 
                Policies - Schedule of Antidilutive Securities                   
                Excluded from Computation of Net Loss Per Share                  
                (Details)                                                        
50: R38         Inventories (Details Narrative)                     HTML     35K 
51: R39         Inventories - Schedule of Components of Inventory   HTML     34K 
                (Details)                                                        
52: R40         Property and Equipment (Details Narrative)          HTML     34K 
53: R41         Property and Equipment - Schedule of Components of  HTML     45K 
                Property and Equipment (Details)                                 
54: R42         Intangible Assets (Details Narrative)               HTML     34K 
55: R43         Intangible Assets - Schedule of Intangible Assets   HTML     41K 
                (Details)                                                        
56: R44         Fair Value Measurements (Details Narrative)         HTML     45K 
57: R45         Fair Value Measurements - Schedule of Financial     HTML     40K 
                Liabilities Measured at Fair Value on Recurring                  
                Basis by Level within Fair Value Hierarchy                       
                (Details)                                                        
58: R46         Fair Value Measurements - Schedule of               HTML     35K 
                Reconciliation of Derivative Liability (Details)                 
59: R47         Fair Value Measurements - Schedule of Assumptions   HTML     42K 
                used in Estimating Fair Value (Details)                          
60: R48         Accrued Liabilities - Schedule of Accrued           HTML     44K 
                Liabilities (Details)                                            
61: R49         Debt (Details Narrative)                            HTML    153K 
62: R50         Debt - Schedule of Outstanding Long-Term Debt       HTML     52K 
                (Details)                                                        
63: R51         Equity (Details Narrative)                          HTML    121K 
64: R52         Stock-Based Compensation - Summary of Stock Option  HTML     80K 
                Activity (Details)                                               
65: R53         Stock-Based Compensation - Schedule of Fair Value   HTML     36K 
                Assumptions of Options (Details)                                 
66: R54         Stock-Based Compensation - Summary of Stock-Based   HTML     39K 
                Compensation Expense (Details)                                   
67: R55         Stock-Based Compensation - Schedule of              HTML     32K 
                Unrecognized Stock-Based Compensation (Details)                  
68: R56         Income Taxes (Details Narrative)                    HTML     43K 
69: R57         Income Taxes - Schedule of Reconciliation           HTML     49K 
                Statutory Federal Income Tax Provision to Actual                 
                Income Tax Benefit (Details)                                     
70: R58         Income Taxes - Schedule of Significant Components   HTML     61K 
                of Deferred Tax Assets and Liabilities (Details)                 
71: R59         Commitment and Contingencies (Details Narrative)    HTML     39K 
72: R60         Commitment and Contingencies - Summary of Future    HTML     38K 
                Minimum Rental Payments Under Operating Leases                   
                (Details)                                                        
73: R61         401(k) Plan (Details Narrative)                     HTML     27K 
74: R62         Restatement to Previously Issued 2016 Consolidated  HTML     36K 
                Balance sheet and Related Statements of                          
                Operations, Stockholders? Equity and Cash Flows                  
                (Details Narrative)                                              
75: R63         Restatement to Previously Issued 2016 Consolidated  HTML     83K 
                Balance sheet and Related Statements of                          
                Operations, Stockholders? Equity and Cash Flows -                
                Restatement To Previously Issued Condensed                       
                Consolidated Financial Statements (Details)                      
76: R64         Restatement to Previously Issued 2017 Condensed     HTML     36K 
                Consolidated Financial Statements (Details                       
                Narrative)                                                       
77: R65         Restatement to Previously Issued 2017 Condensed     HTML     67K 
                Consolidated Financial Statements - Restatement To               
                Interim Period Issued Condensed Consolidated                     
                Financial Statements (Details)                                   
78: R66         Subsequent Events (Details Narrative)               HTML     78K 
80: XML         IDEA XML File -- Filing Summary                      XML    149K 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX     96K 
 7: EX-101.INS  XBRL Instance -- amda-20171231                       XML   1.51M 
 9: EX-101.CAL  XBRL Calculations -- amda-20171231_cal               XML    201K 
10: EX-101.DEF  XBRL Definitions -- amda-20171231_def                XML    623K 
11: EX-101.LAB  XBRL Labels -- amda-20171231_lab                     XML   1.10M 
12: EX-101.PRE  XBRL Presentations -- amda-20171231_pre              XML    880K 
 8: EX-101.SCH  XBRL Schema -- amda-20171231                         XSD    178K 
81: ZIP         XBRL Zipped Folder -- 0001493152-18-004186-xbrl      Zip    152K

‘EX-101.CAL’   —   XBRL Calculations — amda-20171231_cal

This Exhibit is an XBRL XML File.

                                                                                                                                                                                
<?xml version="1.0" standalone="no" encoding="windows-1252"?>
<!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 4.22a -->
<!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
<!-- Field: Doc-Info; Name: Source; Value: AMDA 20171231 10K FY DFN.xfr; Date: 2018%2D03%2D29T19:33:36Z -->
<!-- Field: Doc-Info; Name: Status; Value: 0x80760026 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://amedica.com/role/DocumentAndEntityInformation" xlink:href="amda-20171231.xsd#DocumentAndEntityInformation" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/BalanceSheets" xlink:href="amda-20171231.xsd#BalanceSheets" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/BalanceSheetsParenthetical" xlink:href="amda-20171231.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/StatementsOfOperations" xlink:href="amda-20171231.xsd#StatementsOfOperations" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/StatementsOfStockholdersEquity" xlink:href="amda-20171231.xsd#StatementsOfStockholdersEquity" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/StatementsOfCashFlow" xlink:href="amda-20171231.xsd#StatementsOfCashFlow" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/StatementsOfCashFlowParenthetical" xlink:href="amda-20171231.xsd#StatementsOfCashFlowParenthetical" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" xlink:href="amda-20171231.xsd#OrganizationAndSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Inventories" xlink:href="amda-20171231.xsd#Inventories" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/PropertyAndEquipment" xlink:href="amda-20171231.xsd#PropertyAndEquipment" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IntangibleAssets" xlink:href="amda-20171231.xsd#IntangibleAssets" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurements" xlink:href="amda-20171231.xsd#FairValueMeasurements" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/AccruedLiabilities" xlink:href="amda-20171231.xsd#AccruedLiabilities" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Debt" xlink:href="amda-20171231.xsd#Debt" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Equity" xlink:href="amda-20171231.xsd#Equity" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensation" xlink:href="amda-20171231.xsd#Stock-basedCompensation" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IncomeTaxes" xlink:href="amda-20171231.xsd#IncomeTaxes" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/CommitmentAndContingencies" xlink:href="amda-20171231.xsd#CommitmentAndContingencies" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/KPlan" xlink:href="amda-20171231.xsd#KPlan" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/SubsequentEvents" xlink:href="amda-20171231.xsd#SubsequentEvents" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="amda-20171231.xsd#OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:href="amda-20171231.xsd#OrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/InventoriesTables" xlink:href="amda-20171231.xsd#InventoriesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/PropertyAndEquipmentTables" xlink:href="amda-20171231.xsd#PropertyAndEquipmentTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IntangibleAssetsTables" xlink:href="amda-20171231.xsd#IntangibleAssetsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurementsTables" xlink:href="amda-20171231.xsd#FairValueMeasurementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/AccruedLiabilitiesTables" xlink:href="amda-20171231.xsd#AccruedLiabilitiesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/DebtTables" xlink:href="amda-20171231.xsd#DebtTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensationTables" xlink:href="amda-20171231.xsd#Stock-basedCompensationTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IncomeTaxesTables" xlink:href="amda-20171231.xsd#IncomeTaxesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/CommitmentAndContingenciesTables" xlink:href="amda-20171231.xsd#CommitmentAndContingenciesTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsTables" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsTables" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsTables" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="amda-20171231.xsd#OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails" xlink:href="amda-20171231.xsd#OrganizationAndSummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/InventoriesDetailsNarrative" xlink:href="amda-20171231.xsd#InventoriesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Inventories-ScheduleOfComponentsOfInventoryDetails" xlink:href="amda-20171231.xsd#Inventories-ScheduleOfComponentsOfInventoryDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/PropertyAndEquipmentDetailsNarrative" xlink:href="amda-20171231.xsd#PropertyAndEquipmentDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/PropertyAndEquipment-ScheduleOfComponentsOfPropertyAndEquipmentDetails" xlink:href="amda-20171231.xsd#PropertyAndEquipment-ScheduleOfComponentsOfPropertyAndEquipmentDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IntangibleAssetsDetailsNarrative" xlink:href="amda-20171231.xsd#IntangibleAssetsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:href="amda-20171231.xsd#IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurementsDetailsNarrative" xlink:href="amda-20171231.xsd#FairValueMeasurementsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurements-ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" xlink:href="amda-20171231.xsd#FairValueMeasurements-ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurements-ScheduleOfReconciliationOfDerivativeLiabilityDetails" xlink:href="amda-20171231.xsd#FairValueMeasurements-ScheduleOfReconciliationOfDerivativeLiabilityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/FairValueMeasurements-ScheduleOfAssumptionsUsedInEstimatingFairValueDetails" xlink:href="amda-20171231.xsd#FairValueMeasurements-ScheduleOfAssumptionsUsedInEstimatingFairValueDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails" xlink:href="amda-20171231.xsd#AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/DebtDetailsNarrative" xlink:href="amda-20171231.xsd#DebtDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Debt-ScheduleOfOutstandingLong-termDebtDetails" xlink:href="amda-20171231.xsd#Debt-ScheduleOfOutstandingLong-termDebtDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/EquityDetailsNarrative" xlink:href="amda-20171231.xsd#EquityDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensation-SummaryOfStockOptionActivityDetails" xlink:href="amda-20171231.xsd#Stock-basedCompensation-SummaryOfStockOptionActivityDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensation-ScheduleOfFairValueAssumptionsOfOptionsDetails" xlink:href="amda-20171231.xsd#Stock-basedCompensation-ScheduleOfFairValueAssumptionsOfOptionsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensation-SummaryOfStock-basedCompensationExpenseDetails" xlink:href="amda-20171231.xsd#Stock-basedCompensation-SummaryOfStock-basedCompensationExpenseDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/Stock-basedCompensation-ScheduleOfUnrecognizedStock-basedCompensationDetails" xlink:href="amda-20171231.xsd#Stock-basedCompensation-ScheduleOfUnrecognizedStock-basedCompensationDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IncomeTaxesDetailsNarrative" xlink:href="amda-20171231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IncomeTaxes-ScheduleOfReconciliationStatutoryFederalIncomeTaxProvisionToActualIncomeTaxBenefitDetails" xlink:href="amda-20171231.xsd#IncomeTaxes-ScheduleOfReconciliationStatutoryFederalIncomeTaxProvisionToActualIncomeTaxBenefitDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/IncomeTaxes-ScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="amda-20171231.xsd#IncomeTaxes-ScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/CommitmentAndContingenciesDetailsNarrative" xlink:href="amda-20171231.xsd#CommitmentAndContingenciesDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/CommitmentAndContingencies-SummaryOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" xlink:href="amda-20171231.xsd#CommitmentAndContingencies-SummaryOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/KPlanDetailsNarrative" xlink:href="amda-20171231.xsd#KPlanDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsDetailsNarrative" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows-RestatementToPreviouslyIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows-RestatementToPreviouslyIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsDetailsNarrative" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsDetailsNarrative" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements-RestatementToInterimPeriodIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:href="amda-20171231.xsd#RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements-RestatementToInterimPeriodIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:type="simple"/>
<link:roleRef roleURI="http://amedica.com/role/SubsequentEventsDetailsNarrative" xlink:href="amda-20171231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="loc_us-gaapAccountsReceivableNetCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAccountsReceivableNetCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryGross" xlink:label="loc_us-gaapInventoryGross"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapInventoryGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Goodwill" xlink:label="loc_us-gaapGoodwill"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNoncurrent" xlink:label="loc_us-gaapInventoryNoncurrent"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapInventoryNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="loc_us-gaapLongTermDebtCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLongTermDebtCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapDerivativeLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredRentCreditNoncurrent" xlink:label="loc_us-gaapDeferredRentCreditNoncurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDeferredRentCreditNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="loc_us-gaapOtherLiabilitiesNoncurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapOtherLiabilitiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent" xlink:label="loc_us-gaapDerivativeLiabilitiesNoncurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapDerivativeLiabilitiesNoncurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GrossProfit" xlink:label="loc_us-gaapGrossProfit"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="loc_us-gaapSalesRevenueNet"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapSalesRevenueNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CostOfRevenue" xlink:label="loc_us-gaapCostOfRevenue"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapGrossProfit" xlink:to="loc_us-gaapCostOfRevenue" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_SellingAndMarketingExpense" xlink:label="loc_us-gaapSellingAndMarketingExpense"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapSellingAndMarketingExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapGrossProfit" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestExpenseOther" xlink:label="loc_us-gaapInterestExpenseOther"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseOther" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoninterestExpenseOfferingCost" xlink:label="loc_us-gaapNoninterestExpenseOfferingCost"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapNoninterestExpenseOfferingCost" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherNonoperatingIncome" xlink:label="loc_us-gaapOtherNonoperatingIncome"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapOtherNonoperatingIncome" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="loc_us-gaapIncomeTaxExpenseBenefit"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeTaxExpenseBenefit" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PreferredStockDividendsIncomeStatementImpact" xlink:label="loc_us-gaapPreferredStockDividendsIncomeStatementImpact"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="loc_us-gaapPreferredStockDividendsIncomeStatementImpact" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders' Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/StatementsOfCashFlow" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flow">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_Depreciation" xlink:label="loc_us-gaapDepreciation"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="loc_us-gaapAmortizationOfIntangibleAssets"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfIntangibleAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfLeaseIncentives" xlink:label="loc_us-gaapAmortizationOfLeaseIncentives"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfLeaseIncentives" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AssetImpairmentCharges" xlink:label="loc_us-gaapAssetImpairmentCharges"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAssetImpairmentCharges" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="amda-20171231.xsd#AMDA_NonCashIssuanceOfStockToSettleLitigation" xlink:label="loc_AMDANonCashIssuanceOfStockToSettleLitigation"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AMDANonCashIssuanceOfStockToSettleLitigation" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:label="loc_us-gaapGainsLossesOnExtinguishmentOfDebt"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainsLossesOnExtinguishmentOfDebt" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet"/>
<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="amda-20171231.xsd#AMDA_GainsLossesonExtinguishmentofDerivativeInstruments" xlink:label="loc_AMDAGainsLossesonExtinguishmentofDerivativeInstruments"/>
<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AMDAGainsLossesonExtinguishmentofDerivativeInstruments" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment"/>
<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapGainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="amda-20171231.xsd#AMDA_ProvisionForInventoryReserve" xlink:label="loc_AMDAProvisionForInventoryReserve"/>
<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_AMDAProvisionForInventoryReserve" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts" xlink:label="loc_us-gaapProvisionForDoubtfulAccounts"/>
<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapProvisionForDoubtfulAccounts" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NoninterestExpenseOfferingCost" xlink:label="loc_us-gaapNoninterestExpenseOfferingCost"/>
<link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNoninterestExpenseOfferingCost" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>
<link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
<link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_us-gaapIncreaseDecreaseInInventories"/>
<link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInInventories" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
<link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebt" xlink:label="loc_us-gaapRepaymentsOfDebt"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebt" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_RepaymentsOfDebtAndCapitalLeaseObligations" xlink:label="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfDebtAndCapitalLeaseObligations" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromWarrantExercises" xlink:label="loc_us-gaapProceedsFromWarrantExercises"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromWarrantExercises" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt" xlink:label="loc_us-gaapProceedsFromIssuanceOfDebt"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfDebt" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtExtinguishmentCosts" xlink:label="loc_us-gaapPaymentsOfDebtExtinguishmentCosts"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtExtinguishmentCosts" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts" xlink:label="loc_us-gaapPaymentsOfDebtIssuanceCosts"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfDebtIssuanceCosts" xlink:type="arc" weight="-1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock"/>
<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfPreferredStockAndPreferenceStock" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_ProceedsFromIssuanceOfWarrants" xlink:label="loc_us-gaapProceedsFromIssuanceOfWarrants"/>
<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfWarrants" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/StatementsOfCashFlowParenthetical" xlink:title="00000007 - Statement - Consolidated Statements of Cash Flow (Parenthetical)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Organization and Summary of Significant Accounting Policies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Inventories" xlink:title="00000009 - Disclosure - Inventories"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/PropertyAndEquipment" xlink:title="00000010 - Disclosure - Property and Equipment"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IntangibleAssets" xlink:title="00000011 - Disclosure - Intangible Assets"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurements" xlink:title="00000012 - Disclosure - Fair Value Measurements"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/AccruedLiabilities" xlink:title="00000013 - Disclosure - Accrued Liabilities"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Debt" xlink:title="00000014 - Disclosure - Debt"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Equity" xlink:title="00000015 - Disclosure - Equity"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensation" xlink:title="00000016 - Disclosure - Stock-Based Compensation"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IncomeTaxes" xlink:title="00000017 - Disclosure - Income Taxes"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/CommitmentAndContingencies" xlink:title="00000018 - Disclosure - Commitment and Contingencies"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/KPlan" xlink:title="00000019 - Disclosure - 401(k) Plan"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows" xlink:title="00000020 - Disclosure - Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders&#8217; Equity and Cash Flows"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements" xlink:title="00000021 - Disclosure - Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/SubsequentEvents" xlink:title="00000022 - Disclosure - Subsequent Events"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000023 - Disclosure - Organization and Summary of Significant Accounting Policies (Policies)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesTables" xlink:title="00000024 - Disclosure - Organization and Summary of Significant Accounting Policies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/InventoriesTables" xlink:title="00000025 - Disclosure - Inventories (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/PropertyAndEquipmentTables" xlink:title="00000026 - Disclosure - Property and Equipment (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IntangibleAssetsTables" xlink:title="00000027 - Disclosure - Intangible Assets (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurementsTables" xlink:title="00000028 - Disclosure - Fair Value Measurements (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/AccruedLiabilitiesTables" xlink:title="00000029 - Disclosure - Accrued Liabilities (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/DebtTables" xlink:title="00000030 - Disclosure - Debt (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensationTables" xlink:title="00000031 - Disclosure - Stock-Based Compensation (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IncomeTaxesTables" xlink:title="00000032 - Disclosure - Income Taxes (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/CommitmentAndContingenciesTables" xlink:title="00000033 - Disclosure - Commitment and Contingencies (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsTables" xlink:title="00000034 - Disclosure - Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders&#8217; Equity and Cash Flows (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsTables" xlink:title="00000035 - Disclosure - Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements (Tables)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000036 - Disclosure - Organization and Summary of Significant Accounting Policies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfNetLossPerShareDetails" xlink:title="00000037 - Disclosure - Organization and Summary of Significant Accounting Policies - Schedule of Antidilutive Securities Excluded from Computation of Net Loss Per Share (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/InventoriesDetailsNarrative" xlink:title="00000038 - Disclosure - Inventories (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Inventories-ScheduleOfComponentsOfInventoryDetails" xlink:title="00000039 - Disclosure - Inventories - Schedule of Components of Inventory (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryNet" xlink:label="loc_us-gaapInventoryNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryRawMaterialsAndSupplies" xlink:label="loc_us-gaapInventoryRawMaterialsAndSupplies"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryRawMaterialsAndSupplies" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryWorkInProcess" xlink:label="loc_us-gaapInventoryWorkInProcess"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryWorkInProcess" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InventoryFinishedGoods" xlink:label="loc_us-gaapInventoryFinishedGoods"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapInventoryNet" xlink:to="loc_us-gaapInventoryFinishedGoods" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="00000040 - Disclosure - Property and Equipment (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/PropertyAndEquipment-ScheduleOfComponentsOfPropertyAndEquipmentDetails" xlink:title="00000041 - Disclosure - Property and Equipment - Schedule of Components of Property and Equipment (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IntangibleAssetsDetailsNarrative" xlink:title="00000042 - Disclosure - Intangible Assets (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IntangibleAssets-ScheduleOfIntangibleAssetsDetails" xlink:title="00000043 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsNetExcludingGoodwill"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="loc_us-gaapIntangibleAssetsGrossExcludingGoodwill"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapIntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIntangibleAssetsNetExcludingGoodwill" xlink:to="loc_us-gaapFiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" weight="-1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurementsDetailsNarrative" xlink:title="00000044 - Disclosure - Fair Value Measurements (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurements-ScheduleOfFinancialLiabilitiesMeasuredAtFairValueOnRecurringBasisByLevelWithinFairValueHierarchyDetails" xlink:title="00000045 - Disclosure - Fair Value Measurements - Schedule of Financial Liabilities Measured at Fair Value on Recurring Basis by Level within Fair Value Hierarchy (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurements-ScheduleOfReconciliationOfDerivativeLiabilityDetails" xlink:title="00000046 - Disclosure - Fair Value Measurements - Schedule of Reconciliation of Derivative Liability (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/FairValueMeasurements-ScheduleOfAssumptionsUsedInEstimatingFairValueDetails" xlink:title="00000047 - Disclosure - Fair Value Measurements - Schedule of Assumptions used in Estimating Fair Value (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/AccruedLiabilities-ScheduleOfAccruedLiabilitiesDetails" xlink:title="00000048 - Disclosure - Accrued Liabilities - Schedule of Accrued Liabilities (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccruedLiabilitiesCurrent"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent" xlink:label="loc_us-gaapAccruedSalesCommissionCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedSalesCommissionCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_InterestPayableCurrent" xlink:label="loc_us-gaapInterestPayableCurrent"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapInterestPayableCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="amda-20171231.xsd#AMDA_AccruedFinalLoanPaymentFeesCurrent" xlink:label="loc_AMDAAccruedFinalLoanPaymentFeesCurrent"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_AMDAAccruedFinalLoanPaymentFeesCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/DebtDetailsNarrative" xlink:title="00000049 - Disclosure - Debt (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Debt-ScheduleOfOutstandingLong-termDebtDetails" xlink:title="00000050 - Disclosure - Debt - Schedule of Outstanding Long-Term Debt (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/EquityDetailsNarrative" xlink:title="00000051 - Disclosure - Equity (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensation-SummaryOfStockOptionActivityDetails" xlink:title="00000052 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensation-ScheduleOfFairValueAssumptionsOfOptionsDetails" xlink:title="00000053 - Disclosure - Stock-Based Compensation - Schedule of Fair Value Assumptions of Options (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensation-SummaryOfStock-basedCompensationExpenseDetails" xlink:title="00000054 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/Stock-basedCompensation-ScheduleOfUnrecognizedStock-basedCompensationDetails" xlink:title="00000055 - Disclosure - Stock-Based Compensation - Schedule of Unrecognized Stock-Based Compensation (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000056 - Disclosure - Income Taxes (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IncomeTaxes-ScheduleOfReconciliationStatutoryFederalIncomeTaxProvisionToActualIncomeTaxBenefitDetails" xlink:title="00000057 - Disclosure - Income Taxes - Schedule of Reconciliation Statutory Federal Income Tax Provision to Actual Income Tax Benefit (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/IncomeTaxes-ScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000058 - Disclosure - Income Taxes - Schedule of Significant Components of Deferred Tax Assets and Liabilities (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther"/>
<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits"/>
<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsInventory" xlink:label="loc_us-gaapDeferredTaxAssetsInventory"/>
<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsInventory" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:label="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/CommitmentAndContingenciesDetailsNarrative" xlink:title="00000059 - Disclosure - Commitment and Contingencies (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/CommitmentAndContingencies-SummaryOfFutureMinimumRentalPaymentsUnderOperatingLeasesDetails" xlink:title="00000060 - Disclosure - Commitment and Contingencies - Summary of Future Minimum Rental Payments Under Operating Leases (Details)">
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent"/>
<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>
<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1"/>
<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2017/elts/us-gaap-2017-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear"/>
<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear" xlink:type="arc" weight="1"/>
</link:calculationLink>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/KPlanDetailsNarrative" xlink:title="00000061 - Disclosure - 401(k) Plan (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlowsDetailsNarrative" xlink:title="00000062 - Disclosure - Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders&#8217; Equity and Cash Flows (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2016ConsolidatedBalanceSheetAndRelatedStatementsOfOperationsStockholdersEquityAndCashFlows-RestatementToPreviouslyIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:title="00000063 - Disclosure - Restatement to Previously Issued 2016 Consolidated Balance sheet and Related Statements of Operations, Stockholders&#8217; Equity and Cash Flows - Restatement To Previously Issued Condensed Consolidated Financial Statements (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatementsDetailsNarrative" xlink:title="00000064 - Disclosure - Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements (Details Narrative)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/RestatementToPreviouslyIssued2017CondensedConsolidatedFinancialStatements-RestatementToInterimPeriodIssuedCondensedConsolidatedFinancialStatementsDetails" xlink:title="00000065 - Disclosure - Restatement to Previously Issued 2017 Condensed Consolidated Financial Statements - Restatement To Interim Period Issued Condensed Consolidated Financial Statements (Details)"/>
<link:calculationLink xlink:type="extended" xlink:role="http://amedica.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000066 - Disclosure - Subsequent Events (Details Narrative)"/>
</link:linkbase>

↑Top
Filing Submission 0001493152-18-004186   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Tue., Apr. 30, 2:07:04.1am ET